| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Safety and tolerability of methylphenidate in preschool children with ADHD.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
10.19
|
|
2
|
Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS).
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
10.00
|
|
3
|
Stimulant-related reductions of growth rates in the PATS.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
9.98
|
|
4
|
Pharmacogenetics of methylphenidate response in preschoolers with ADHD.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
9.85
|
|
5
|
The Columbia-Suicide Severity Rating Scale: initial validity and internal consistency findings from three multisite studies with adolescents and adults.
|
Am J Psychiatry
|
2011
|
9.18
|
|
6
|
Sudden death and use of stimulant medications in youths.
|
Am J Psychiatry
|
2009
|
4.33
|
|
7
|
Practice parameter for the assessment and treatment of children and adolescents with depressive disorders.
|
J Am Acad Child Adolesc Psychiatry
|
2007
|
3.39
|
|
8
|
Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters.
|
Arch Gen Psychiatry
|
2002
|
2.76
|
|
9
|
The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up.
|
J Am Acad Child Adolesc Psychiatry
|
2013
|
2.48
|
|
10
|
Posttraumatic stress disorder comorbid with major depression: factors mediating the association with suicidal behavior.
|
Am J Psychiatry
|
2005
|
1.78
|
|
11
|
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
1.63
|
|
12
|
Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
1.39
|
|
13
|
Peripubertal suicide attempts in offspring of suicide attempters with siblings concordant for suicidal behavior.
|
Am J Psychiatry
|
2003
|
1.32
|
|
14
|
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment study of Children With ADHD (MTA): part I: executive summary.
|
J Atten Disord
|
2008
|
1.27
|
|
15
|
Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
|
Arch Pediatr Adolesc Med
|
2006
|
1.26
|
|
16
|
Familial transmission of suicidal behavior: factors mediating the relationship between childhood abuse and offspring suicide attempts.
|
J Clin Psychiatry
|
2008
|
1.19
|
|
17
|
Evidence, interpretation, and qualification from multiple reports of long-term outcomes in the Multimodal Treatment Study of children with ADHD (MTA): Part II: supporting details.
|
J Atten Disord
|
2008
|
1.18
|
|
18
|
Human 5-HT1A receptor C(-1019)G polymorphism and psychopathology.
|
Int J Neuropsychopharmacol
|
2004
|
1.16
|
|
19
|
Familial transmission of mood disorders: convergence and divergence with transmission of suicidal behavior.
|
J Am Acad Child Adolesc Psychiatry
|
2004
|
1.09
|
|
20
|
ADHD treatment with once-daily OROS methylphenidate: interim 12-month results from a long-term open-label study.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
1.09
|
|
21
|
Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders.
|
J Am Acad Child Adolesc Psychiatry
|
2005
|
1.05
|
|
22
|
Factor structure of parent- and teacher-rated attention-deficit/hyperactivity disorder symptoms in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).
|
J Child Adolesc Psychopharmacol
|
2007
|
0.97
|
|
23
|
Pharmacokinetics of methylphenidate in preschoolers with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2007
|
0.97
|
|
24
|
Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.
|
J Child Adolesc Psychopharmacol
|
2014
|
0.90
|
|
25
|
Treatment of pediatric anxiety disorders: an open-label extension of the research units on pediatric psychopharmacology anxiety study.
|
J Child Adolesc Psychopharmacol
|
2002
|
0.90
|
|
26
|
Once-daily OROS methylphenidate is safe and well tolerated in adolescents with attention-deficit/hyperactivity disorder.
|
J Child Adolesc Psychopharmacol
|
2006
|
0.88
|
|
27
|
Steady-state bioavailability of extended-release methylphenidate (MPH-MLR) capsule vs. immediate-release methylphenidate tablets in healthy adult volunteers.
|
Clin Drug Investig
|
2014
|
0.88
|
|
28
|
Early childhood sexual abuse increases suicidal intent.
|
World Psychiatry
|
2013
|
0.85
|
|
29
|
No association between a TPH2 promoter polymorphism and mood disorders or monoamine turnover.
|
J Affect Disord
|
2007
|
0.85
|
|
30
|
Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government.
|
J Am Acad Child Adolesc Psychiatry
|
2006
|
0.84
|
|
31
|
Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders.
|
J Am Acad Child Adolesc Psychiatry
|
2003
|
0.81
|
|
32
|
The open-label treatment of attention-deficit/hyperactivity disorder in 4- and 5-year-old children with beaded methylphenidate.
|
J Child Adolesc Psychopharmacol
|
2009
|
0.79
|
|
33
|
Familial transmission of parental mood disorders: unipolar and bipolar disorders in offspring.
|
Bipolar Disord
|
2013
|
0.78
|
|
34
|
Efficacy of Methylphenidate Hydrochloride Extended-Release Capsules (Aptensio XR™) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Phase III, Randomized, Double-Blind Study.
|
CNS Drugs
|
2015
|
0.77
|